Akerblom, L.

monkey iscom virus antibody vaccine challenge protein gp 70 preparation group immunization titre elisa protection figure serum felv iscoms group b rhesu analysis infection rhesus pbmc siv-iscom siv-mdp sivmac gpl 20 dilution animal method siv-specific development table cell-associated siv wb analysis siv vaccine preparations c 8166 cells experiment response stock immunity study vaccine preparations envelope siv-iscom-immunized 6 weeks gpl 20-inhibition elisa sds-polyacrylamide gel electrophoresis gpl 20-enriched iscoms siv-specific immunity siv-mdp-immunized monkeys siv-iscom-immunized monkeys aids res siv-immunized monkeys cell-associated presence iscom preparation disease immunodeficiency siv-mdp-immunized macaque leukemia pl 5e siv-infected vaccination 4 weeks 32-inhibition gpl 20- inhibition siv infection hiv -2 infection aids vaccine developments gp 32-inhibition elisa e e k -751 23 uppsala gp 32-inhibition elisas postchallenge anti-gp 70 mab pl 5 e f 422 cells immunodeficiency virus infection